IAM is currently seeking nominations for individuals to be considered for the 2020 edition of the Strategy 300 - our unique guide to the men and women who excel in the creation of IP value
A good result in a German court and the settlement of a key competitor dispute are among positive signs for the company, but US sanctions continue to cloud future
The country’s Constitutional Court, which split down the middle, refused to grant an appeal to challenge a Merck patent on new grounds
Exact terms remain confidential, but TSMC's CEO suggested to employees that the licence rights are not transferrable should Globalfoundries be acquired
Shenzhen Transsion, the dominant mobile phone seller on the African continent, said to have come into IP conflict with Huawei shortly before going public
TSMC is the target and nineteen other tech firms are in the crossfire. Here are the takeaways from a big chip sector dispute that’s taking on a trade war tinge
Special IAM boardroom session at IPBC Global 2019 focuses on how to get more women involved in senior positions in the global IP market - and why everyone will win when it happens
Saudi Aramco claims victory in PTAB showdown as Korean refiner faces second IP setback in as many weeks
Shenzhen-based Transsion is a dominant market player in Africa, but a light IP portfolio might complicate its ambitious expansion plans
IAM's annual benchmarking survey is designed to identify the key concerns of senior decision makers in areas such as deal-making, valuation, patent office performance, top litigation venues and policy
The annual search for outstanding individuals to induct into the IP Hall of Fame starts today and we want your help.
The Korean electronics giant has bought Corephotonics, an Israeli startup that is taking on Apple in Judge Lucy Koh’s Northern District of California courtroom
New IAM research reports identify the key trends shaping the global IP market – and tell you how to respond
There is not much time left to make nominations for the 2019 edition of IAM Strategy 300, our exclusive guide on the world's best IP strategists.
In June’s round-up of life sciences-related news, we report on the US Supreme Court’s decision to grant certiorari in the Helsinn Healthcare v Teva Pharmaceuticals Section 102 dispute, but not in the Cleveland Clinic’s Section 101 case against True…